Michael Astrue
Director/Board Member bij The National Alliance For Hispanic Health
Profiel
Michael James Astrue currently works at The National Alliance For Hispanic Health, as Director from 2016.
Mr. Astrue also formerly worked at Transkaryotic Therapies, Inc., as President & Chief Executive Officer, EPIX Pharmaceuticals, Inc., as Chief Executive Officer, Invivo Therapeutics Holdings Corp., as Chief Executive Officer from 2013 to 2014, VIVUS, Inc., as Non-Executive Chairman from 2013 to 2014, ArQule, Inc., as Director, CuraGen Corp., as Director from 2005 to 2006, Tercica, Inc., as Director from 2005 to 2006, Biogen MA, Inc., as Secretary, Vice President & General Counsel from 1993 to 1999, and Joslin Diabetes Center, Inc., as Trustee.
Mr. Astrue received his undergraduate degree from Yale University and graduate degree from Harvard Law School.
Actieve functies van Michael Astrue
| Bedrijven | Functie | Begin |
|---|---|---|
The National Alliance For Hispanic Health
 The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | Director/Board Member | 25-02-2016 |
Eerdere bekende functies van Michael Astrue
| Bedrijven | Functie | Einde |
|---|---|---|
| VIVUS, INC. | Chairman | 12-09-2014 |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Executive Officer | 06-01-2014 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Director/Board Member | 13-10-2006 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Director/Board Member | 12-10-2006 |
| ARQULE, INC. | Director/Board Member | 12-10-2006 |
Opleiding van Michael Astrue
| Yale University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | Health Services |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Health Technology |
